Clinical Trials Directory

Trials / Completed

CompletedNCT02956473

Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research study involves the use of a common breast imaging modality (magnetic resonance imaging, 'MRI') and is investigating its role in evaluating surgical decision making for breast cancer when it is performed with the patient in a new position (lying on one's back) as opposed to in the standard position (lying on one's stomach).

Detailed description

The procedure involved is called a supine breast magnetic resonance imaging (MRI).In this study, the investigators are evaluating the value of supine MRI in surgical decision making for women with breast cancer either undergoing upfront surgery or for those anticipating surgery after receiving neoadjuvant therapy. The purpose of this study is to assess the value of supine breast MRI as a new imaging method to assist in surgical treatment planning. It is possible that the use of supine breast MRI will help your doctor see the size and location of tumors more accurately

Conditions

Interventions

TypeNameDescription
DEVICESupine MRI
OTHERNeoadjuvant Therapy (NAT)
DEVICEUltrasound
DEVICEMammography
PROCEDUREStandard of Care
DEVICEStandard MRI

Timeline

Start date
2016-11-15
Primary completion
2022-08-01
Completion
2022-08-01
First posted
2016-11-07
Last updated
2024-03-12
Results posted
2024-03-12

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02956473. Inclusion in this directory is not an endorsement.